Gene-expression profiles of a hepatitis B small surface antigen-secreting cell line reveal upregulation of lymphoid enhancer-binding factor 1

Journal of General Virology

Volumn 88, Issue 11, 2007, Pages 2966-2976

  Tian, Xiaochen ^a   Zhao, Chao ^a   Ren, Jun ^a   Ma, Zhang Mei ^a   Xie, You Hua ^a   Wen, Yu Mei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HEPATITIS B SURFACE ANTIGEN; ISOPROTEIN; LYMPHOID ENHANCER FACTOR 1; PROTEIN X; SMALL INTERFERING RNA; VIRUS ENVELOPE PROTEIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; GENE EXPRESSION PROFILING; HEPATITIS B; HEPATITIS B VIRUS; HOST CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; VIRION; VIRUS GENOME;

ANIMALS; CELL LINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

HEPATITIS B VIRUS; MUS MUSCULUS;

EID: 36248984332     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83108-0     Document Type: Article

References (42)

1. Alexander, J. J., Bey, E. M., Geddes, E. W. & Lecatsas, G. (1976). Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50, 2124-2128.
2. Beasley, R. P., Shiao, I. S., Wu, T. C. & Hwang, L. Y. (1982). Hepatoma in an HBsAg carrier-seven years after perinatal infection. J Pediatr 101, 83-84.
3. Cha, M. Y., Kim, C. M., Park, Y. M. & Ryu, W. S. (2004). Hepatitis B virus X protein is essential for the activation of Wnt /β-catenin signaling in hepatoma cells. Hepatology 39, 1683-1693.
4. Cheng, J., Imanishi, H., Morisaki, H., Liu, W., Nakamura, H., Morisaki, T. & Hada, T. (2005). Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFκB pathwayin ahuman monocytic cell line, THP-I. J Hepatol 43, 465-471.
5. Chisari, F. V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H. A., Sell, S., Pinkert, C. A., Brinster, R. L. & Palmiter, R. D. (1989). Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59, 1145-1156.
6. Clayton, R. F., Owsianka, A. & Patel, A. H. (2001). Evidence for structural differences in the S domain of L in comparison with S protein of hepatitis B virus. J Gen Virol 82, 1533-1541.
7. Clevers, H. & van de Wetering, M. (1997). TCF/LEF factors earn their wings. Trends Genet 13, 485-489.
8. Cordray, P. & Satterwhite, D. J. (2005). TGF-β induces novel Lef-1 splice variants through a Smad-independent signaling pathway. Dev Dyn 232, 969-978.
9. Coyle-Rink, J., Del Valle, L., Sweet T., Khalili, K. & Amini, S. (2002). Developmental expression of Wnt signaling factors in mouse brain. Cancer Biol Ther 1, 640-645.
10. de La Coste, A., Romagnolo, B., Billuart, P., Renard, C. A., Buendia, M. A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C. & other authors (1998). Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 95, 8847-8851.
11. Ding, Q., Xia, W., Liu, J. C., Yang, J. Y., Lee, D. F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y. & other authors (2005). Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin. Mol Cell 19, 159-170.
12. Eastman, Q & Grosschedl, R. (1999). Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11, 233-240.
13. Ganem, D. & Prince, A. M. (2004). Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350, 1118-1129.
14. Giles, R. H., van Es, L. H. & Clevers, H. (2003). Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653, 1-24.
15. Hildt, E., Munz, B., Saher, G., Reifenberg, K. & Hofschneider, P. H. (2002). The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 21, 525-535.
16. Hovanes, K., Li, T. W. & Waterman, M. L. (2000). The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 28, 1994-2003.
17. Hovanes, K, Li, T. W., Munguia, J. E., Truong, T., Milovanovic, T., Lawrence Marsh, J., Holcombe, R. F. & Waterman, M. L. (2001). β-Catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28, 53-57.
18. Kato, T., Satoh, S., Okabe, H., Kitahara, O., Ono, K., Kihara, C., Tanaka, T., Tsunoda, T., Yamaoka, Y. & other authors (2001). Isolation of a novel human gene, MARKLI, homologous to MARK3 and its involvement in hepatocellular carcinogenesis. Neoplasia 3, 4-9.
19. Khan, N., Guarnieri, M., Ahn, S. H., Li, J., Zhou, Y., Bang, G., Kim, K. H., Wands, J. R. & Tong, S. (2004). Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J Virol 78, 3262-3270.
20. Lee, W. M. (1997). Hepatitis B virus infection. N Engl J Med 337, 1733-1745.
21. Lee, T. K, Man, K., Ho, J. W, Wang, X. H., Poon, R. T., Xu, Y., Ng, K. T., Chu, A. C., Sun, C. K. & other authors (2005). FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res 11, 8458-8466.
22. Lee, H. C., Kim, M. & Wands, J. R. (2006). Wnt/Frizzled signaling in hepatocellular carcinoma. Front Biosci 11, 1901-1915.
23. Li, Y., Wasser, S., Lim, S. G. & Tan, T. M. (2004). Genome-wide expression profiling of RNA interference of hepatitis B virus gene expression and replication. Cell Mol Life Sci 61, 2113-2124.
24. Locarnini, S., Shaw, T., Dean, J., Colledge, D., Thompson, A., Li, K., Lemon, S. M., Lau, G. G. & Beard, M. R. (2005). Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. J Clin Virol 32, 113-121.
25. Lupberger, J. & Hildt, E. (2007). Hepatitis B virus-induced oncogenesis. World J Gastroenterol 13, 74-81.
26. Milich, D. R. (1997). Immune response to the hepatitis B virus: infection, animal models, vaccination. Viral Hepatitis Rev 3, 63-103.
27. Nakanishi, F., Ohkawa, K., Ishida, H., Hosul, A., Sato, A., Hiramatsu, N., Ueda, K., Takehara, T., Kasahara, A. & other authors (2005). Alteration in gene expression profile by full-length hepatitis B virus genome. Intervirology 48, 77-83.
28. Ng, R. K., Lau, C. Y., Lee, S. M, Tsui, S. K, Fung, K. P. & Waye, M. M. (2004). cDNA microarray analysis of early gene expression profiles associated with hepatitis B virus X protein-mediated hepatocarcino-genesis. Biochem Biophys Res Commun 322, 827-835.
29. Ocama, P., Opio, C. K. & Lee, W. M. (2005). Hepatitis B virus infection: current status. Am J Med 118, 1413.e15-1413.e22.
30. Rehermann, B. & Nascimbeni, M. (2005). Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5, 215-229.
31. Roberts, L. R. & Gores, G. J. (2005). Hepatocellular carcinoma: molecular pathways and new therapeutic targets. Semin Liver Dis 25, 212-225.
32. Schmitt-Graeff, A., Ertelt-Heitzmann, V, Allgaier, H. P, Olschewski, M., Nitschke, R., Haxelmans, S, Koelble, K., Behrens, I & Blum, H. E. (2005). Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma. Liver Int 25, 839-847.
33. Seeger, C. & Mason, W. S. (2000). Hepatitis B virus biology. Microbiol Mol Biol Rev 64, 51-68.
34. Sells, M. A., Chen, M. L. & Acs, G. (1987). Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 84, 1005-1009.
35. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R. & Ben-Ze'ev, A. (1999). The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96, 5522-5527.
36. Tetsu, O. & McCormick, F. (1999). β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426.
37. Vanlandschoot P. & Leroux-Roels, G. (2003). Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus? Trends Immunol 24, 144-147.
38. Wang, X. & Seed, B. (2003). A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31, e154.
39. Wang, W., Ji, P., Steffen, B., Metzger, R., Schneider, P. M., Halfter, H., Schrader, M., Berdel, W. E., Serve, H. & Muller-Tidow, C. (2005). Alterations of lymphoid enhancer factor- I isoform expression in solid tumors and acute leukemias. Acta Biochim Biophys Sin (Shanghai) 37, 173-180.
40. Wen, Y. M., Copeland, I A., Mann, G. F, Howard, C. R. & Zuckerman, A. J. (1981). Detection of HBsAg in a clone derived from the PLC/ PRF/5 human hepatoma cell line. Arch Viral 68, 157-163.
41. Wu, C. G., Salvay, D. M., Forgues, M., Valerie, K, Farnsworth, J., Markin, R. S. & Wang, X. W. (2001). Distinctive gene expression profiles associated with hepatitis B virus x protein. Oncogene 20, 3674-3682.
42. Yang, H. I., Lu, S. N., Liaw, Y. F., You, S. L., Sun, C. A., Wang, L. Y., Hsiao, C. K., Chen, P. J., Chen, D. S. & Chen, C. J. (2002). Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347, 168-174.